Drug regulator slaps notice to Johnson and Johnson for violating legal provisions in product ad

Image
Press Trust of India New Delhi
Last Updated : Mar 06 2019 | 12:00 AM IST

The Drug Controller General of India has asked Johnson & Johnson to explain why did it violated statutory provisions and issued advertisements citing a government laboratory test report on its baby powder to say that the product is free of asbestos.

The DGCI issued the show cause notice to the multinational company pointing out that publication of any advertisement on the basis of any test report of a government analyst is not permissible under Section 29 of the of Drugs and Cosmetics Act, 1940.

The drug inspectors earlier on DCGI orders had seized samples of the firm's various baby products from wholesalers, retailers and distributors across the country in December.

The regulator had ordered Johnson and Johnson not to use talc raw material from its Mulund plant in Mumbai and Baddi unit in Himachal Pradesh for production till further directions.

According to a senior Central Drugs Standard Control Organisation (CDSCO) official, the samples of raw materials were tested in Central Drugs Laboratory and were found to be free of asbestos.

The test result was also conveyed to J&J, which used the result to promote its product, he added.

"It has come to the CDSCO's notice that advertisements had been published in various national and regional newspapers recently, inter alia with the heading: 'Your Johnson's baby powder is pure, safe & gentle; Government lab tests confirm Johnson's baby powder is asbestos-free," the notice said.

The notice further pointed out that "publication of any advertisement on the basis of test reports of government analyst is not permissible under Section 29 of the Drugs and Cosmetics Act, 1940."

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 06 2019 | 12:00 AM IST

Next Story